• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物刺激的人P-糖蛋白ATP酶活性需要跨膜片段6和12之间的移动。

Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.

作者信息

Loo T W, Clarke D M

机构信息

Medical Research Council Group in Membrane Biology, Department of Medicine and Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada M5S 1A8.

出版信息

J Biol Chem. 1997 Aug 22;272(34):20986-9. doi: 10.1074/jbc.272.34.20986.

DOI:10.1074/jbc.272.34.20986
PMID:9261097
Abstract

Transmembrane segments (TM) 6 and 12 are directly connected to the ATP-binding domain in each homologous half of P-glycoprotein and are postulated to be important for drug-protein interactions. Cysteines introduced into TM6 (L332C, F343C, G346C, and P350C) were oxidatively cross-linked to cysteines introduced into TM12 (L975C, M986C, G989C, and S993C, respectively). The pattern of cross-linking was consistent with a left-handed coiled coil arrangement of the two helices. To detect conformational changes between the helices during drug-stimulated ATPase activity, we tested the effects of substrates and ATP on cross-linking. Cyclosporin A, verapamil, vinblastine, and colchicine inhibited cross-linking of mutants F343C/M986C, G346C/G989C, and P350C/S993C. By contrast, ATP promoted cross-linking between only L332C/L975C. Enhanced cross-linking between L332C/L975C was due to ATP hydrolysis, since cross-linked product was not observed in the presence of ATP and vanadate, ADP, ADP and vanadate, or AMP-PNP. Cross-linking between P350C/S993C inhibited verapamil-stimulated ATPase activity by about 75%. Drug-stimulated ATPase activity, however, was fully restored in the presence of dithiothreitol. These results show that TM6 and TM12 undergo different conformational changes upon drug binding or during ATP hydrolysis, and that movement between these two helices is essential for drug-stimulated ATPase activity.

摘要

跨膜片段(TM)6和12直接连接到P-糖蛋白每个同源半体中的ATP结合结构域,据推测对药物与蛋白质的相互作用很重要。引入TM6的半胱氨酸(L332C、F343C、G346C和P350C)分别与引入TM12的半胱氨酸(L975C、M986C、G989C和S993C)发生氧化交联。交联模式与两个螺旋的左手卷曲螺旋排列一致。为了检测药物刺激的ATP酶活性过程中螺旋之间的构象变化,我们测试了底物和ATP对交联的影响。环孢素A、维拉帕米、长春碱和秋水仙碱抑制了突变体F343C/M986C、G346C/G989C和P350C/S993C的交联。相比之下,ATP仅促进L332C/L975C之间的交联。L332C/L975C之间交联增强是由于ATP水解,因为在ATP和钒酸盐、ADP、ADP和钒酸盐或AMP-PNP存在下未观察到交联产物。P350C/S993C之间的交联使维拉帕米刺激的ATP酶活性抑制约75%。然而,在二硫苏糖醇存在下,药物刺激的ATP酶活性完全恢复。这些结果表明,TM6和TM12在药物结合或ATP水解过程中经历不同的构象变化,并且这两个螺旋之间的移动对于药物刺激的ATP酶活性至关重要。

相似文献

1
Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.药物刺激的人P-糖蛋白ATP酶活性需要跨膜片段6和12之间的移动。
J Biol Chem. 1997 Aug 22;272(34):20986-9. doi: 10.1074/jbc.272.34.20986.
2
Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.核苷酸结合、ATP水解以及人P-糖蛋白催化性羧酸盐的突变会导致跨膜区段发生不同的构象变化。
Biochemistry. 2007 Aug 14;46(32):9328-36. doi: 10.1021/bi700837y. Epub 2007 Jul 18.
3
Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.人P-糖蛋白跨膜片段中底物诱导的构象变化。药物结合底物诱导契合机制的直接证据。
J Biol Chem. 2003 Apr 18;278(16):13603-6. doi: 10.1074/jbc.C300073200. Epub 2003 Feb 27.
4
Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates.药物底物对人P-糖蛋白预测跨膜片段(TM)6中第332位和预测TM12中第975位工程化半胱氨酸残基之间氧化交联的抑制作用。
J Biol Chem. 1996 Nov 1;271(44):27482-7. doi: 10.1074/jbc.271.44.27482.
5
Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix.底物三(2-马来酰亚胺乙基)胺对人多药耐药性P-糖蛋白的交联作用会因ATP水解而改变。跨膜螺旋旋转的证据。
J Biol Chem. 2001 Aug 24;276(34):31800-5. doi: 10.1074/jbc.M103498200. Epub 2001 Jun 27.
6
The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis.通过二硫键交联分析揭示了人类多药耐药性P-糖蛋白跨膜片段的组装情况。
J Biol Chem. 2000 Feb 25;275(8):5253-6. doi: 10.1074/jbc.275.8.5253.
7
Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.两种不同药物同时结合于人多药耐药性P-糖蛋白的结合口袋中。
J Biol Chem. 2003 Oct 10;278(41):39706-10. doi: 10.1074/jbc.M308559200. Epub 2003 Aug 7.
8
Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane.二硫键交联分析表明,人P-糖蛋白的跨膜片段5和8在膜的细胞质侧彼此靠近。
J Biol Chem. 2004 Feb 27;279(9):7692-7. doi: 10.1074/jbc.M311825200. Epub 2003 Dec 10.
9
Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites.罗丹明和维拉帕米的甲硫基磺酸盐衍生物在不同位点激活人P-糖蛋白。
J Biol Chem. 2003 Dec 12;278(50):50136-41. doi: 10.1074/jbc.M310448200. Epub 2003 Oct 1.
10
Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate.使用硫醇反应性底物鉴定人P-糖蛋白药物结合位点中的残基。
J Biol Chem. 1997 Dec 19;272(51):31945-8. doi: 10.1074/jbc.272.51.31945.

引用本文的文献

1
Conversion of Human Multidrug Transporter P-glycoprotein (ABCB1) from Drug Efflux to Uptake Pump: Evidence for a Switch Region Modulating the Direction of Substrate Transport.人类多药转运蛋白P-糖蛋白(ABCB1)从药物外排泵向摄取泵的转变:调控底物转运方向的转换区域的证据
J Mol Biol. 2025 Apr 1;437(7):168979. doi: 10.1016/j.jmb.2025.168979. Epub 2025 Feb 1.
2
New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.新型 P-糖蛋白介导的淀粉样β肽在分子、血脑屏障和神经元模型中的外排证据。
Int J Mol Sci. 2020 Dec 29;22(1):246. doi: 10.3390/ijms22010246.
3
Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein.
逆转人多药耐药转运蛋白 P-糖蛋白介导的药物转运方向。
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29609-29617. doi: 10.1073/pnas.2016270117. Epub 2020 Nov 9.
4
Evaluation of a Novel Missense Mutation in Gene Causing Progressive Familial Intrahepatic Cholestasis Type 3.评估导致进行性家族性肝内胆汁淤积症 3 型的基因中的一种新型错义突变。
Dis Markers. 2020 Jun 15;2020:6292818. doi: 10.1155/2020/6292818. eCollection 2020.
5
Dissecting the Forces that Dominate Dimerization of the Nucleotide Binding Domains of ABCB1.解析 ABCB1 核苷酸结合域二聚化的主要作用力。
Biophys J. 2018 Jan 23;114(2):331-342. doi: 10.1016/j.bpj.2017.11.022.
6
Comparison of mechanistic transport cycle models of ABC exporters.ABC 外排泵的机械转运循环模型比较。
Biochim Biophys Acta Biomembr. 2018 Apr;1860(4):818-832. doi: 10.1016/j.bbamem.2017.10.028. Epub 2017 Oct 31.
7
Unidirectional Transport Mechanism in an ATP Dependent Exporter.ATP 依赖性转运体中的单向转运机制
ACS Cent Sci. 2017 Mar 22;3(3):250-258. doi: 10.1021/acscentsci.7b00068. Epub 2017 Mar 7.
8
Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity.多药转运蛋白P-糖蛋白的结构揭示了不对称ATP结合及多特异性机制。
J Biol Chem. 2017 Jan 13;292(2):446-461. doi: 10.1074/jbc.M116.755884. Epub 2016 Nov 18.
9
Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.维拉帕米与结合于外排转运体P-糖蛋白的ATP之间的协同作用。
Biochem Pharmacol. 2016 Oct 15;118:96-108. doi: 10.1016/j.bcp.2016.08.013. Epub 2016 Aug 13.
10
Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein.绘制稳定P-糖蛋白第一跨膜结构域的抑制剂塔里喹达的结合位点图谱。
J Biol Chem. 2015 Dec 4;290(49):29389-401. doi: 10.1074/jbc.M115.695171. Epub 2015 Oct 26.